Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Gorilla Game -- Ignore unavailable to you. Want to Upgrade?

To: Larry Southam who wrote (47)	3/31/1998 9:58:00 PM
From: Lane	Respond to of 387

Thats correct...... currently to use either of the two lasers approved by the FDA for laser vision correction, a fee has to be paid to the manufacturers. Its called Pillar Point and is about $250 per procedure. No ifs, ands or buts......to use either of the only two choices for lasers, the fee has to be paid via a prepaid key card. That is what the antitrust case involves. The companies formed a joint venture to charge this fee...Pillar Point. The general consensus among those that use the lasers is that Visx is the better mouse trap. Summit is behind the curve in both FDA approval and software upgrades for the correction of astigmatism. FWIW.